Cargando…
2148. In vitro Potency of a Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Against Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium abscessus
BACKGROUND: The family of Mycobacteriaceae contains hundreds of species, some causing diseases in humans. The most well-known is Mycobacterium tuberculosis (Mtb), the causative agent for tuberculosis. Approximately 2 billion people are infected with M. tuberculosis. Drug-resistant strains of M. tube...
Autores principales: | Shoen, Carolyn M, DeStefano, Michelle S, Wang, Wen, Cynamon, Michael H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679245/ http://dx.doi.org/10.1093/ofid/ofad500.1771 |
Ejemplares similares
-
A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo
por: Wu, Wenye, et al.
Publicado: (2022) -
1704. Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, Demonstrates Potent Efficacy and Improves Efficacy of Standard of Care Regimen Against Mycobacterium avium complex in a Chronic Mouse Lung Infection Model
por: De, Kavita, et al.
Publicado: (2022) -
Therapy for Mycobacterium kansasii Infection: Beyond 2018
por: DeStefano, Michelle S., et al.
Publicado: (2018) -
Desiccation-Tolerance of Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium chimaera, Mycobacterium abscessus and Mycobacterium chelonae
por: Falkinham, Joseph O., et al.
Publicado: (2022) -
Crucial role of the C-terminal domain of Mycobacterium tuberculosis leucyl-tRNA synthetase in aminoacylation and editing
por: Hu, Qing-Hua, et al.
Publicado: (2013)